Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on GABA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1314684C details a novel Tiagabine synthesis route avoiding expensive organometallics, offering cost reduction and scalable manufacturing for global pharmaceutical supply chains.
Patent CN102093237B reveals a novel phase transfer method for gabapentin hydrochloride. This process eliminates inorganic salt waste and enables continuous production for reliable supply chains.
Advanced chiral synthesis of pregabalin via dibenzylamine intermediates. Reduces genotoxic risks and improves scalability for reliable API manufacturing supply chains.
Advanced manufacturing of (S)-4-isobutyl-dihydro-3H-furan-2-one via a novel Grignard route. Offers significant cost reduction and scalable production for pharmaceutical intermediates.
Novel chemical-enzymatic route for Mirogabalin ensures high purity and yield. Ideal for reliable API supply chain partners seeking cost-effective manufacturing solutions.
Patent CN110105212B reveals an iron-mediated Reformatsky reaction offering cost-effective routes for high-purity pharmaceutical intermediates with broad functional group tolerance.
Struggling with toxic reagents in pregabalin synthesis? Discover near-critical water technology for 97% purity & 70% yield. Find reliable GMP suppliers now.